AZN
AstraZeneca PLCHealthcare · $255.6B market cap
Verdict
Share price
$156.90
close of Oct 3, 2026
Fair value
$249.32
Sticker Price
Payback Price
$99.73
buy price
AZN is Undervalued: at $156.90 it trades 37% below its fair value of $249.32. Its buy price (Payback Price) is $99.73, 36% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Owner Earnings. Earnings have been shrinking, but the business still generates cash, so we value it on its cash flow instead of its earnings.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow AZN
Get notified when it reaches its buy price of $99.73. Free.
Create a free accountSuperinvestors
3 of the investors we track hold AZN. In Q2 2026, 1 added and 1 trimmed. Who we track
Insider activity
Since Jun 8, 2026: 1 open-market purchase worth $3K and 4 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
Other filings
About AstraZeneca PLC
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and…
Drug Manufacturers - General
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works